News Releases

BioVectra Named Agent of Reagent Proteins' Products
Companies will cooperate in the sales and distribution of high value reagent proteins to the North American and European markets

Charlottetown, PE & San Diego, CA - June 2013 - BioVectra announced today a new agreement naming BioVectra as a non-exclusive agent of Reagent Proteins in North America and Europe.  BioVectra will provide its customers access to Reagent Proteins’ unique range of over 5,000 catalog protein products; as well as actively promoting Reagent Proteins’ capabilities through its agency network and directly to its key customers, including the potential for custom projects.

“We are pleased to establish this distribution relationship with BioVectra." stated Patrick K. Lucy, Vice President, Business Development and Marketing at Pfenex Inc., “Leveraging BioVectra’s experienced business development and sales team, as well as an extensive supply chain network, provides the North American and European markets with additional access to our catalog of proteins and services.” 

“BioVectra is proud to add the Reagent Proteins catalog to our portfolio of products and services including: cGMP custom manufacturing and key cGMP reagents and both biologic and synthetic API’s, from fermentation, synthesis, and natural product extraction,” Heather Delage, Director of Worldwide Sales & Marketing at BioVectra said, “This cGMP experience makes BioVectra a unique agent, able to leverage its operations and quality assurance understanding to meet the exact individual needs of biologic drug manufacturers.” 
 
About Reagent Proteins
Located in San Diego, California, Reagent Proteins is a leading manufacturer and supplier of reagent, pre-clinical and cGMP grade recombinant proteins to the biopharmaceutical and vaccine development community.  Reagent Proteins is a division of Pfenex Inc. Headquartered in San Diego, California, Pfenex is a biotechnology company leveraging the proprietary Pfenex Expression Technology™ platform for the development of biosimilars and innovative vaccines to address unmet and growing global healthcare needs. 
 
About BioVectra
Based in Prince Edward Island, Canada, BioVectra Inc. is an innovative cGMP drug development partner, custom manufacturer of API’s and bioprocess reagent supplier with over 40 years of experience serving the pharmaceutical, diagnostic and biotechnology industries. BioVectra is the world’s leading manufacturer of dithiothreitol (DTT).  The company holds 8 DMF and 2 VMF filings, and has experience in technology-partnering and development of API’s for both NCE and generic development pathways.
 
BioVectra contact:                                                                Reagent Proteins contact:
 
Lee DesRosiers                                                                     Cassidy Brady
Product Manager, Bioprocess Reagents                        Business Development

(514) 246-5266                                                                       (858) 344-7207
ldesrosiers@biovectra.com                                                 cbrady@pfenex.com
 
T: (866) 883-2872 / (902) 566-9116
info@biovectra.com
 

                                                 For more information, please visit us at: 
                          www.biovectra.com    www.reagentproteins.com    www.pfenex.com